- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
ETNK1 Antibody / Ethanolamine kinase 1 Antibody recognizes an enzyme that catalyzes the phosphorylation of ethanolamine to phosphoethanolamine, the first committed step of the CDP-ethanolamine branch of the Kennedy pathway. This pathway supplies phosphatidylethanolamine, a major membrane phospholipid involved in bilayer organization, membrane curvature, and the function of numerous membrane-associated proteins. By controlling entry of ethanolamine into this biosynthetic route, ETNK1 contributes to the metabolic processes that maintain cellular membrane composition.
Following formation of phosphoethanolamine, additional enzymes convert it to CDP-ethanolamine and then incorporate the phosphoethanolamine head group into diacylglycerol. The resulting phosphatidylethanolamine is distributed among cellular membranes and participates in membrane remodeling. Phosphatidylethanolamine also contributes to mitochondrial membrane physiology and provides a lipid component required for conjugation reactions during autophagy. The Kennedy pathway is one of several routes influencing phosphatidylethanolamine abundance, so its contribution must be considered alongside lipid transport and alternative synthesis mechanisms.
ETNK1 uses ATP as the phosphate donor and belongs to a small family of ethanolamine kinase enzymes. Its catalytic activity is distinct from the subsequent cytidylyltransferase and phosphotransferase reactions in the pathway. Changes in ethanolamine phosphorylation can affect the balance of free ethanolamine and phosphoethanolamine, potentially influencing metabolic networks beyond the final production of membrane phospholipids.
Somatic ETNK1 mutations have been identified in certain myeloid neoplasms, including atypical chronic myeloid leukemia and chronic myelomonocytic leukemia. Experimental studies have associated some mutations with altered enzymatic activity and phosphoethanolamine metabolism. These findings have prompted investigation into links among phospholipid precursors, mitochondrial physiology, and oxidative stress, although the full disease mechanism remains incompletely resolved.
NSJ Bioreagents offers this ETNK1 Antibody to help explore ethanolamine phosphorylation and its connections to membrane lipid metabolism and myeloid disease biology. ETNK1 illustrates how an early reaction in a biosynthetic pathway can influence both the supply of structural lipids and broader metabolic regulation.
Explore related research targets in our Metabolism Antibody / Metabolism Antibodies collection.
For best results, determine the optimal working dilution of the ETNK1 Antibody / Ethanolamine kinase 1 Antibody experimentally.
The ETNK1 Antibody was generated using e. coli-derived human ETNK1 recombinant protein (amino acids S10-Q401).
Once reconstituted, refrigerate the ETNK1 Antibody at 4oC for no longer than one month. For extended storage, freeze aliquots at -20oC for up to six months and avoid repeated freeze-thaw cycles.
ETNK1 antibody, Ethanolamine kinase 1 antibody, EKI1 antibody, EKI 1 antibody, ETNK1 rabbit polyclonal antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.